Sponsor Pipeline

Hospital Authority, Hong Kong Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
5
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 4
1
Phase 2/3
1
Not specified
4
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06742307 Faricimab Quarterly Maintenance for Neovascular Age Related Macular Degeneration Macular Degeneration Choroidal Neovascularization Recruiting
Phase 2/3
NCT06719024 Topical Ruxolitinib for Face and Neck Vitiligo of Adult Chinese Patients Refractory to… Vitiligo Recruiting
Not specified
NCT06473844 Efficacy of SGLT2 Inhibitors in Adults With Sepsis Sepsis Recruiting
NCT07005973 Effects of Mobile-based Mindfulness Intervention to Reduce Preoperative Anxiety for… Mobile-based Mindfulness Intervention to Reduce Preoperative Anxiety Recruiting
NCT07058623 Nurse-Led Telehealth vs In-Person Follow-Up After Total Knee Replacement Arthroplasty, Replacement, Knee Recruiting
NCT06559254 TDCS as Augmentation Therapy to Cognitive Training in Mild Dementia Major Neurocognitive Disorder Not Yet Recruiting
Disease Areas
Get alerts when Hospital Authority, Hong Kong's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free